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Antimicrobial resistance is a global problem that needs 
an urgent action. The irrational use of antibiotics is wide-
spread and leads to potential usefulness of medicines 
and negative therapeutic outcome.In April 2016, WHO 
stated that the problem of antibiotic resistance is a 
major clinical problem resulting in treatment failures 
even in a case ofeasy to treat diseases. Resistance to 
first line medicines results in huge spending on new 
generation of antibiotics. In some instances resistance 
to second- and third-line agents is seriously compromi-
sing treatment outcome.Seriousness of the situation 
requires extensive research and constantly monitoring 
of the spread of bacteria resistance.Another problem 
regarding bacteria resistance is the lack of new anti-
biotics reported by the US Center for Control and 
Prevention of Disease.A systematic literature search of 
databasesgave us enough information about the use of 
antibiotics, most often isolated bacteria and resistance 
to different classes of antibiotics. According to the 
official data, bacterial resistance is lowest in the 
countries where guidelines for prescribing and use of 
antibiotics are consistently implemented, such as 
Scandinavian countries, The Netherlands, Germany 
and Great Britain. It is necessary to create a complete 
database of bacterial resistance and information on 
whether patients receive medicines appropriate to their 
clinical conditionin our country.   
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Бактериската резистенција претставува голем здрав-
ствен проблем за кој е потребно итно делување. 
Нерационалната употреба на антибиотици е широ-
ко распространета и е една од најзначајните при-
чини за зголемување на резистенцијата инегативни 
терапевтски исходи. Во април 2016 година, СЗО 
изјави дека проблемот со отпорноста на анти-
биотици е голем клинички проблем што резултира 
со неуспех во лекувањето, дури и во случаи кога 
станува збор за болести кои вообичаено лесно се 
лекуваат. Отпорноста на лековите од прва линија 
резултира со зголемување на потрошувачката на 
новите генерации на антибиотици. Во некои слу-
чаи, отпорноста кон антибиотиците од втора и тре-
та линија сериозно го компромитираат исход од 
третманот. Сериозноста на состојбата во однос на 
развојот на бактериската резистенција, бара опширно 
истражување на овој феномен и  постојано следење 
на резистенцијата на бактериите. Во извештајот об-
јавен од страна на американскиот Центар за кон-
трола и превенција на болести се вели дека допол-
нителна причина за бактериската резистенција е 
недостигот од нови антибиотици.Систематското пре-
барување на литературната база на податоци, ни 
даде доволно информации за употреба на анти-
биотиците, најчесто изолирани бактерии и нивната 
отпорност на различни класи на антибиотици. Спо-
ред официјалните податоци, бактериската резистен-
ција е најниска во земјите во кои насоките за пре-
пишување и користење на антибиотици доследно 
се спроведуваат, како Скандинавските земји, Холан-
дија, Германија и Англијa. Во нашата држава неоп-
ходно е да се создаде база на податоци по однос на 
ова прашање и информациите за рационална фар-
макотерапија. 
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Bacterial resistance is not a new phenomenon butmajor 
public health concern. It was recognized in the earlier 
1950s as a threat to effective treatment outcome. Since 
the WHO Resolution, many countries have expressed 
growing concern about the problem of antimicrobial 
resistance [1,2]. Reporting about bacterial resistance 
and monitoring the use of antibiotics today is an obli-
gation for all countries. 
The most endangered population for acute infectious 
disease as a result of bacterial resistance are children. 
Collective accommodation in kindergartens or schools, 
unhygienic living conditions, insufficiently effective 
immune system, as well as irrational, empirical and 
excessive use of antibiotics, especially unjustified in 
viral infections are the most common reasons for the 
frequent occurrence of bacterial infections in children 
[3-5]. Receiving antibiotics for prophylaxis increases 
the risk of multidrug resistance among recurrent infec-
tions [6]. In hospital acquired infections in children, 
antibiotic resistance is frequently reported in clinical 
Gram-negative bacteria. The number of available thera-
peutic options for treatment of these conditions is 
limiteddue to the lack of novel active antibiotics [7]. 
At the end of the 20th century, the attention regarding 
the threat of antibiotic resistance of the scientific and 
pharmaceutical companies was focused on multidrug 
resistant Gram-positive bacteria [8]. 
In order to understand bacterial resistance, there is a huge 
need to interpret molecular mechanisms of antibiotic 
resistance, especially to Gram-negative and Gram-posi-
tive clinical pathogens [9-11]. 
Among the diseases that have been declared as "alar-
ming threat" are severe forms of clostridium-induced 
diarrhea and gonorrhea infections. But, the most serious 
infections are those coming from enterobacteria that 
cause relatively new and rare, but deadly infections 
resistant to carbapenems. For such infections it is stated 
that they cannot be cured with so-called spare anti-
biotics, which confirms the fact that no new antibiotic 
has been synthesized for a long period of time [12,13]. 
However, we are now faced with the threat of a post-
antibiotic era [14,15]. 
An interesting fact is that bacteria isolated in children 
younger than 2 years show a higher percentage of 
antibiotic resistance compared to bacteria isolated in 
older children [5]. Also, isolated bacteria in the hos-
pitals are more resistant than those isolated in primary 
health care [16]. The situation is particularly proble-
matic at the University clinics where patients from 
other regional hospitals who have already received 
antibacterial therapy come up. That is the possible 
reason for the occurrence of resistant and multidrug 
resistant bacterial strains [17]. 
Bacterial resistance is a global problem that must be 
resolved locally, having in mind that there are signifi-
cant geographical variations in the participation of cer-
tain resistant strains, as the triggers of bacterial infec-
tions. Methicillin-resistant Staphylococcus aureus (MRSA), 
vancomycin-resistant Enterococcus (VRE), Mycobacterium 
tuberculosis and Streptococcus pneumoniae are the 
most frequent pathogens who have a significant impact 
on morbidity and mortality [18].  
It is important to highlight that the UN and the WHO 
organization have developed action plans to reduce 
antimicrobial resistance in all healthcare settings. They 
establish the institutional antimicrobial stewardship 
program as a key intervention to reduce antibiotic 
consumption in hospitals. The goal was to address 
high rates of multi-drug-resistant bacteria [19]. 
 
Materials and methods  
 
For the purpose of this paper, a systematic literature 
search of Medline/Pubmed and Embasedatabases was 
done in order to evaluate the phenomenon of bacterial 
resistance and multidrug resistance published in the 
last fifteen years.  
A systematic review of Randomized Controlled Trials 
(RCTs) was made until December 2018 using the follo-
wing key words: antibiotics, bacterial resistance, mul-
tidrug resistance, pharmacoepidemiology. We identified 
3287 reports, of which only 32 articleswere subject of 
evaluation (Figure 1). 
Potential analyses, diagnostic criteria, appropriate se-
lection of patients with infections caused by bacteria 
and therapy were used as criteria for evaluating the 
study. 
In our analysis bacterial strain wasconsidered to be 
multidrug resistant if it wasresistant to three or more 




Three main points were the subject of our research: 
use of antibiotics, analysis of isolated bacteria and 











         Fig. 1. Flow of Studies Through the Review Process 
 
Use of antibiotics 
 
The analyzed data available from the database for hos-
pitals and general practice within the SACAR project 
(Specialist Advisory Committee on Antimicrobial Resis-
tance) [20] shows the existence of seasonal variations 
in prescription of antibiotics. Prescription in the winter 
period is about 15% higher compared to the summer 
period. The use of antibiotics was higher in East 
European countries compared to northern EU 
countries [20-21]. 
The use ofpenicillin in hospitals in many European 
countries is low, although the antimicrobial effect of 
penicillin is still relatively well preserved [22]. A study 
conducted at the University of California San Fran-
cisco [23] confirms that from 16 classes of antibac-
terial drugs used, 5 classes are considered safe for pe-
diatric use: beta-lactams+inhibitor, oral and parenteral 
cephalosporins, macrolides and aminoglycosides. Similar 
results have also been reportedinone study conducted 
in China in the period from 2002 to 2006. The most 
commonly used antibiotics in five children's hospitals 
in China were amoxicillin+clavulanic acid and paren-
teral cephalosporins [24]. Penicillins were the most 
common prescribed in children younger than 5 years 
 in six primary health-care facilities in Burkina Faso, 
followed by sulfonamides and macrolides [25]. The 
results of a two-month study [26] conducted at the 
University Clinic in Bari, Italy, showed that amikacin 
and a combination of ampicillin + sulbactam were the 
most used antibiotics in children younger than two 
years. The most common antibiotics were used for 
treatment of respiratory infections in children, at the 
pulmonary departments [5,27]. The results of the 
multicentric multinational study conducted within the 
ARPECproject (Antibiotic Resistance and Prescribing 
in European Children) in September 2011 report a 
high level of use of antibiotics in the departments for 
pediatric hematology/oncology. In this one-day data of 
the use of antibiotics in hospitalized children 73 hos-
pitals worldwide were included [28]. One study con-
ducted in 1992 in three University hospitals in Estonia, 
Sweden and Spain showed that the use of antibiotics at 
the surgical departments was 30-50% higher than in 
other departments [29]. 
Five primary data collection studies, across the five 
countries, conducted between 2014-2017 as part of 
MARVEL (Multi-country economic and epidemiological 
burden of varicella study), examined empiric data on 
the appropriate and inappropriate use of antibiotics in 
the treatment of pediatric varicella patients. In this 
study 787 patient were included and the proportion of 
antibiotics prescribed without a probable or confirmed 
diagnosis of bacterial infection was high (ranged from 
45% to 90%) [30]. 
 
Analysis of isolated bacteria 
 
Analysis of microbiological isolate along with the 
antibiogram is one of the preconditions for optimal 
antibiotic use. For that goal,a sample of patients for 
microbiological analysis is taken before the start of 
therapy and the cause of the infection isisolated. The 
most common samples for bacteriological analysis are 
blood samples-blood cultures. The most commonly 
isolated bacteria from the blood cultures are coagulase 
 





negative Staphylococcus spp., which is normally pre-
sent on the human skin. Therefore, it is very important 
to properly interpret the bacteriologically positive 
blood cell finding [31]. A study in England, conducted 
inneonatal departments in the period from 1992 to 
2005, showed an increase of isolated coagulase nega-
tive Staphylococcus spp. in blood samples, which was 
partly explained by the increased use of central 
vascular catheters in these children [18]. In one study 
conducted in theperiod from 2001 to 2004 inthe 
Houston Hospital (USA) in respiratory tract samples, a 
double increase in the number of isolates in which S. 
aureus (771/1562) was reported, were explained by 
the increased virulence of this bacterium [32]. E. coli, 
the most common cause of urinary tract infections, 
was the most commonly isolated bacteria from urine 
samples [33].In urine cultures the most isolated 
pathogenic gram-negative bacilli are associated with 
resistance to beta-lactam antibiotics [34].In the 
samples of the gastrointestinal tract (GIT), Klebsiella 
pneumoniae, E. coli (16.5%) and Pseudomonas aeru-
ginosa (15.8%) are most often isolated. The results of 
one retrospective study carried out ina hospital in 
Caracas (Venezuela) from 1997 to 2003 showed the 
presence of Pseudomonas aeruginosa in 7% of the 
positive GIT samples [29]. Streptococcus pyogenes 
was the most commonly isolated bacteria in naso-
pharyngeal swabs in healthy children (ages of 6 and 7 
years) who attended the same primary school.  Posi-
tive bacterial findings of this pathogenic in healthy ca-
rriers are not an indication for antibiotic therapy [35]. 
 
Resistance and multidrug resistance of the most 
commonly isolated bacteria 
 
According to literature data, the level of resistance to 
bacteria isolated in hospitals is higher comparing 
tothat in the general practice [36]. Hospitals are often 
regarded as the focal point for emergence development 
of resistance and multidrug resistance [37]. 
E. coli: One-year prospective study conducted in Ankara 
(Turkey) demonstrated about 30% resistance ofE. coli, 
isolated in urinary infections to ceftriaxone. The resis-
tance of ampicillin described in this study was 74.2% 
[38]. Many authors believe that this high percentage of 
resistance of E. coli is a consequence of irrational, 
prophylactic and excessive use of antibiotics in general 
practice [33]. 
S. aureus: S. aureus is usually isolated insamples from 
the respiratory tract. This bacterium isin a relatively 
small percentage multidrug resistant (about 10%). 
Based on the results of five-year retrospective studies 
conducted in 300 hospitals across the United States, an 
increase in methicillinresistant S. aureus (MRSA) 
isolated from swabs of the throat was observed [39].  
Coagulase negative Staphylococcus spp., according to 
literature data, is highly resistant and multidrug resis-
tant bacteria, which again is a result ofan inadequate 
use of antibiotics [40]. Thisbacterium is isolated mainly 
from blood samples and catheter swabs. The sensiti-
vity of this bacterium remained preserved only on van-
comycin and teicoplanin. Regarding fusidic acid it was 
reported that this bacteriawas almost 30% resistant. 
Furthermore, isolates from hospital material showed 
significant resistance to this bacterium tolincosamines 
and macrolides [41].  
Klebsiella pneumoniaeismost commonly isolated from 
samples of the respiratory tractand it is a causative 
factor for sepsis in neonates. For this bacteriumdata 
reported from the studies conducted in Asia, Africa 
and South America shows a high percentage of resis-
tance to many classes of antibiotics: more than 50% 
tocefotaxime, more than 70% to ampicillin and genta-
micin [30]. Isolates of thisbacterium from the blood 
cultures showed significantly high resistance to amino-
glycosides [41]. According to the results of a study con-
ducted in Ankara (Turkey), isolates of K. pneumoniae 
from urinary samples showed about 35% resistance to 
folate synthesis inhibitors [38]. 
Penicillin-resistant Streptococcus pneumoniae was stu-
died in only one RTC with 35 participants. Before expo-
sure to penicillin, resistance was not significant, but 
after exposure to amoxicillin the changes in resistance 
occur and normalized one month after the end of treat-
ment [42]. 
Pseudomonas aeruginosa is a common cause of hos-
pital infections [43]. It is mostly isolated from samples 
from the respiratory tract and less from urine and GIT. 
This bacterium shows 100% resistance to folate syn-
thesis inhibitors and ceftriaxone [44]. It also shows 
high resistance (about 90%) to antibiotics that are usually 
prescribed in general practice such as amoxicillin, 
nitrofurantoin, and cephalexin [45]. 60% of the isola-
tes were sensitive only to quinolones [41].  
Acinetobacter spp. has been shown to be highly resis-
tant to most of the includedantibiotics, and appropriate 
treatment results have been achieved by a combination 
of a beta-lactam antibiotic and aminoglycoside [46]. 
Multidrug resistance of Gram-negative bacteria is a 
major problem in hospitals because it is easily trans-
mitted through contact, and the spread of resistance 
affects many patients in a small area, especially in 
immunologically compromised patients [47].  
Enterobacter spp. in the developing countries is a 
common cause of bacteremia and severe complications 
in newborns. A study analyzing isolates from the res-
piratory and gastrointestinal tract showed a high per-
centage of resistance to penicillin and cephalosporins, 
which is a consequence of the production of beta-
lactamase [30]. In Sweden, in adults, this bacterium 
showed about 20-30% resistance to cefotaxime [48]. 
Enterococcus spp. takes a more prominent place 
among the causes of hospital infections [49]. Isolates 
from urine samples showed the lowest percentage of 
 





multidrug resistance (about 36%), while resistance to 
GIT, blood and catheter isolates wasmuch higher (around 
88%) in all tested classes of antibiotics [50]. According 
to the results of the international SENTRY project 
(The SENTRY Antimicrobial Surveillance Program), 
which included about 70 microbial laboratories around 
the world, a high percentage of resistance (about 50-




According to the literature data, the highest percentage 
of antibiotic consumption is at the surgicalclinics. The 
most commonly used antibiotics in children are paren-
teral and oral cephalosporins, combinations of beta-
lactams+inhibitor (clavulinic acid), macrolides and 
aminoglycosides. The most commonly isolated bacteria 
from the samples are E. coli, S. aureus, coagulase ne-
gative Staphylococcus spp., Klebsiella spp., Pseudomonas 
spp., Acinetobacter spp., Enterococcus spp. and 
Enterobacter spp. Multidrug resistance has been 
confirmed in almost all isolates of Enterobacter spp. 
and Acinetobacter spp. In the remaining isolates of P. 
aeruginosa, Enterococcus spp., resistance has been 
confirmed in more than 50% of the isolates. Insigni-
ficant multidrug resistance has been identified in iso-
lates ofE. coli and S. aureus. 
This data gave us enough information about the use of 
antibiotics, most often isolated bacteria and resistance 
to different classes of antibiotics. This will be very 
helpful in the process of monitoring, completing and 
comparing data for bacterial resistance in our country.  
 




1. WHO Global Strategy for Containment of Antimicrobial 
Resistance, HO/CDS/CSR/DRS/2001.2.  
2. World Health Organization Antibiotic Resistance: Multi-
Country Public Awareness Survey (WHO, 2015); available 
at http://go.nature.com/2ptdypm. 
3.   Hahn GH, Koch A, Melbye M, Molbak K. Pattern of drug 
prescription for children under the age of four years in a 
population in Greenland. Acta Paediatr 2005; 94(1): 99-106. 
4.   Linder JA, Bates DW, Lee GM, Finkelstein JA. Antibiotic 
treatment of children with sorethroat. JAMA 2005; 
294(18): 2315-2322. 
5. Henderson KL, Muller-Pebody B, Johnson AP, Goossens 
H, Sharland M; ARPEC Group. First set-up meeting for 
Antibiotic Resistance and Prescribing in European 
Children (ARPEC). Euro Surveill 2009; 14(45) pii: 19404. 
6. Rachel E Selekman, Daniel J Shapiro, John Boscardin et 
al. Uropathogen Resistance and Antibiotic Prophylaxis: A 
Meta-analysis. Pediatrics 2018; vol. 142 / issue 1. 
7. Pages JM. [Antibiotic transport and membrane permeabi-
lity: new insights to fight bacterial resistance]. BiolAujourdhui 
2017; 211(2): 149-154. French 
8. Ishan Ghai, Shashank Ghai. Understanding antibiotic resistan-
ce via outer membrane permeability. Infection and Drug 
Resistance 2018; 11: 523-530. 
9. Winterhalter M, Ceccarelli M. Physical methods to quan-
tify small antibiotic molecules uptake into Gram-negative 
bacteria. Eur J Pharm Biopharm 2015; 95(Pt A): 63-67.  
10. Ghai I. Quantifying the Flux of Charged Molecules through 
Bacterial Membrane Proteins. Bremen: IRC-Library, Information 
Resource Center der Jacobs University Bremen 2017.  
11. Ghai I, Ghai S. Exploring bacterial outer membrane barrier to 
combat bad bugs. Infect Drug Resist 2017; 10: 261-273. 
12. Cars O, Anthony S, Hogberg L, Manz C. Innovating for 
Antibacterial Resistence. ESCMID News 2007; 02: 22-24. 
13. Cars O, Hogberg LD, Murray M, et al. Meeting the 
challenge of antibiotic resistance. BMJ 2008; 337: a1438. 
14. O'Neill J, Davies S, Rex J, et al. The review on 
antimicrobial resistance: tackling drug-resistant infections 
globally: final report and recommendations. https://amr-
review.org/Publications.html. Accessed 20 Dec 2017. 2016.  
15. WHO. Global antimicrobial resistance surveillance system 
(GLASS) report: early implementation 2016-2017. Geneva: 
World Health Organization 2017. 
16. Al-Tawfiq JA, Anani AA. Antimicrobial susceptibility pattern 
of bacterial pathogens causing urinary tract infections in a 
Saudi Arabian hospital. Chemotherapy 2009; 55(2): 127-131. 
17. Arsenijevic Lj, Popovic N, Gojnic M. Nozokomijalne 
infekcije u jedinici intenzivne terapije Klinike za Ginekologiju. 
Med Pregl 2006; 59(3-4): 165-168. 
18. Whitney P Caron, Shaker A Mousa. Prevention strategies 
for antimicrobial resistance: a systematic review of the 
literature. Infection and Drug Resistance 2010; 3: 25-33. 
19.  Araujo da Silva AR,  Albernaz de Almeida Dias DC,  
Marques AF, et al. Role of antimicrobial stewardship 
programmes in children: a systematic review. Journal of 
Hospital Infection 2018; 99(2): 117-123. 
20. Sharland M, SACAR Paediatric Subgroup. The use of 
antibacterials in children: a report of the Specialist Advisory 
Committee on Antimicrobial Resistance (SACAR) Paediatric 
Subgroup. J Antimicrob Chemother 2007; 60(1): i15-i26. 
21. Elseviers MM, Ferech M, Vander Stichele RH, et al. 
Antibiotic use in ambulatory care in Europe (ESAC data 
1997-2002): trends, regional differences and seasonal fluc-
tuations. Pharmacoepidemiol Drug Saf 2007; 16(1): 115-123. 
22. Cizman M, Beovic B, Krcmery V, et al. Antibiotic policies in 
Central Eastern Europe. Int J Antimicrob Agents 2004; 
24(3): 199-204. 
23. UCSF, 2013. 
24. Zhang W, Shen X, Bergman U, et al. Drug utilisation 90% 
(DU90%) profiles of antibiotics in five Chinese children's 
hospitals (2002-2006). Int J Antimicrob Agents 2008; 
32(3): 250-255. 
25. Ali Sié, Boubacar Coulibaly, Sawadogo Adama, et al. 
Antibiotic Prescription Patterns among Children Younger 
than 5 Years in Nouna District, Burkina Faso. The American 
Journal of Tropical Medicine and Hygiene Available online: 28 
January 2019. DOI: https://doi.org/10.4269/ajtmh.18-0791. 
26. Dell'Aera M, Gasbarro AR, Padovano M, et al. Unlicensed 
and off-label use of medicines at a neonatology clinic in 
Italy. Pharm World Sci 2007; 29(4): 361-367. 
27. Sarahroodi S, Arzi A. Self-medication with antibiotics, is 
it a problem among Iranian college students in Tehran. J 
Biol Sci 2009; 9: 829-832. 
28. Versporten A, Sharland M, Bielicki J, et al. The antibiotic 
resistance and prescribing in European Children project: a 
neonatal and pediatric antimicrobial web-based point preva-
 





lence survey in 73 hospitals worldwide. Pediatr Infect Dis 
J 2013; 32(6): e242-e253. 
29. Kiivet RA, Dahl ML, Llerena A, et al. Antibiotic use in 3 
European university hospitals. Scand J Infect Dis 1998; 
30(3): 277-280. 
30. Wolfson L, Giglio N, Castillo M, at al. The Use of Antibiotics 
in the Treatment of Pediatric Varicella Patients: Evidence 
from the multi-country MARVEL study. International 
Journal of Infectious Diseases 2018; 73S: 3-398.  
31.   Zaidi AK, Huskins WC, Thaver D, et al. Hospital-acquired 
neonatal infections in developing countries. Lancet 2005; 
365(9465): 1175-1188. 
32. Kaplan SL. Community-acquired methicillin-resistant Staphy-
lococcus aureus infections in children. SeminPediatr Infect 
Dis 2006; 17(3): 113-119. 
33. Ilic K, Jakovljevic E, Skodric-Trifunovic V. Social-economic 
factors and irrational antibiotic use as reasons for antibiotic 
resistance of bacteria causing common childhood infec-
tions in primary healthcare. Eur J Pediatr 2012; 171(5): 
767-777. 
34. Catherine S Forster, Eleanor A Powell, Barbara De 
Burger, et al. Association of systemic antimicrobials with 
the expression of beta-lactamases in bacteria cultured from 
urological patients. Diagnostic Microbiology and Infectious 
Disease Available online 10 February 2019, https://doi.org/ 
10.1016/j.diagmicrobio.2019.02.007. 
35. Kostic M, Bedekovic V, Bastijancic-Kokic B, Lauc T. 
Unnecessary prescribing of antibiotics to healthy/asym-
ptomatic school-age carriers of potentially pathogenic 
bacteria. Saudi Med J 2019; 40(4): 405-408. 
36. Rodriguez-Morales AJ, Rodriguez CN, Garcia A, et al. 
Antimicrobial resistance of Pseudomonas aeruginosa in 
pediatric infections. Int J Infect Dis 2007; 11(1): 84-85. 
37. WHO Collaborating Centre for Drug Statistics Methodology. 
Guidelines for ATC classification and DDD assignment 
2013. Oslo, 2012. 
38. Yuksel S, Ozturk B, Kavaz A, et al. Antibiotic resistance 
of urinary tract pathogens and evaluation of empirical 
treatment in Turkish children with urinary tract infections. 
Int J Antimicrob Agents 2006; 28(5): 413-416. 
39. Naseri I, Jerris RC, Sobol SE. Nationwide trends in pediatric 
Staphylococcus aureus head and neck infections. Arch 
Otolaryngol Head Neck Surg 2009; 135(1): 14-16. 
40. Kamat U, Ferreira A, Savio R, Motghare D. Antimicrobial 
resistance among nosocomial isolates in a teaching hospital in 
goa. Indian J Community Med 2008; 33(2): 89-92. 
41. Jakovljevic E, Ilic K, Jelesic Z, Konstantinidis G. A one-
year prospective study on the antibiotic resistance of E. 
coli strains isolated in urinary specimens of children 
hospitalized at the University Pediatric Medical Center in 
Novi Sad, Serbia. Infection 2013; 41(6): 1111-1119. 
doi: 10.1007/s15010-013-0493-0. 
42. Malhotra-Kumar S, Van Heirstraeten L, Coenen S, et al. 
Impact of amoxicillin therapy on resistance selection in 
patients with community-acquired lower respiratory tract 
infections: a randomized, placebo-controlled study. J 
Antimicrob Chemother 2016; 71(11): 3258-3267. 
43. Caselli D, Cesaro S, Ziino O, et al. Infection Study Group 
of the Associazione Italiana Ematologia Oncologia Pediatrica 
(AIEOP). Multidrug resistant Pseudomonas aeruginosa infec-
tion in children undergoing chemotherapy and hemato-
poietic stem cell transplantation. Haematologica 2010; 
95(9): 1612-1615. 
44. Murray PR, Baron EJ, Jorgensen JH, et al. Manual of 
clinical microbiology, 9th ed. Washington DC: ASM Press; 
2007. 2008; 36(5): 421-426. 
45. Marcus N, Ashkenazi S, Samra Z, et al. Community-acquired 
Pseudomonas aeruginosa urinary tract infections in children 
hospitalized in a tertiary center: relative frequency, risk 
factors, antimicrobial resistance and treatment. Infection. 
Infection 2008; 36(5): 421-426. 
46.   Rahal JJ. Novel antibiotic combinations against infections 
with almost completely resistant Pseudomonas aeruginosa 
and Acinetobacter species. Clin Infect Dis 2006; 43(2): S95-S99. 
47.   Sharma R, Sharma CL, Kapoor B. Antibacterial resistance: 
current problems and possible solutions. Indian J Med Sci 
2005; 59(3): 120-129. 
48. Hanberger H, Burman LG, Cars O, et al. Low antibiotic 
resistance rates in Staphylococcus aureus, Escherichia coli 
and Klebsiella spp but not in Enterobacter spp and 
Pseudomonas aeruginosa: a prospective observational study 
in 14 Swedish ICUs over a 5-year period. Acta Anaesthesiol 
Scand 2007; 51(7): 937-941. 
49. Turnidge J. Multiresistant organisms at the front line. Aust 
Prescr 2010; 33: 68-71. 
50. Kapoor L, Randhawa VS, Deb M. Antimicrobial resistance 
of enterococcal blood isolates at a pediatric care hospital 
in India. Jpn J Infect Dis 2005; 58(2): 101-103. 
51. Hoban DJ, Doern GV, Fluit AC, et al. Worldwide preva-
lence of antimicrobial resistance in Streptococcus pneumo-
niae, Haemophilus influenzae, and Moraxella catarrhalis in 
the SENTRY Antimicrobial Surveillance Program, 1997-
1999. Clin Infect Dis 2001; 32(2): S81-S93. 
 
